BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25208984)

  • 1. [Sarcomatoid malignant mesothelioma: a clinicopathologic and immunohistochemical analysis of 22 cases].
    Lao I; Chen Q; Yu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):364-9. PubMed ID: 25208984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.
    Marchevsky AM; LeStang N; Hiroshima K; Pelosi G; Attanoos R; Churg A; Chirieac L; Dacic S; Husain A; Khoor A; Klebe S; Lantuejoul S; Roggli V; Vignaud JM; Weynard B; Sauter J; Henderson D; Nabeshima K; Galateau-Salle F
    Hum Pathol; 2017 Sep; 67():160-168. PubMed ID: 28782639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis.
    Piao ZH; Zhou XC; Chen JY
    Virchows Arch; 2021 Aug; 479(2):257-263. PubMed ID: 33570661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and pathologic features of extrapleural sarcomatoid mesothelioma].
    Wei MC; Yang SJ
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):559-564. PubMed ID: 28810297
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.
    Attanoos RL; Dojcinov SD; Webb R; Gibbs AR
    Histopathology; 2000 Sep; 37(3):224-31. PubMed ID: 10971698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of D2-40 in the differential diagnosis of pleural neoplasms with emphasis on its positivity in solitary fibrous tumor.
    Hu Y; Yang Q; McMahon LA; Wang HL; Xu H
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):411-3. PubMed ID: 20436345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.
    Galateau Salle F; Le Stang N; Nicholson AG; Pissaloux D; Churg A; Klebe S; Roggli VL; Tazelaar HD; Vignaud JM; Attanoos R; Beasley MB; Begueret H; Capron F; Chirieac L; Copin MC; Dacic S; Danel C; Foulet-Roge A; Gibbs A; Giusiano-Courcambeck S; Hiroshima K; Hofman V; Husain AN; Kerr K; Marchevsky A; Nabeshima K; Picquenot JM; Rouquette I; Sagan C; Sauter JL; Thivolet F; Travis WD; Tsao MS; Weynand B; Damiola F; Scherpereel A; Pairon JC; Lantuejoul S; Rusch V; Girard N
    J Thorac Oncol; 2018 Aug; 13(8):1189-1203. PubMed ID: 29723687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study.
    Lucas DR; Pass HI; Madan SK; Adsay NV; Wali A; Tabaczka P; Lonardo F
    Histopathology; 2003 Mar; 42(3):270-9. PubMed ID: 12605647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
    Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
    Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of pulmonary sarcomatoid carcinoma mimicking malignant mesothelioma].
    Inomata M; Kawagishi Y; Yamada T; Miwa T; Hayashi R; Kashii T; Matsui S; Fukuoka J; Tobe K
    Nihon Kokyuki Gakkai Zasshi; 2010 Jan; 48(1):33-8. PubMed ID: 20163019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcomatoid Peritoneal Mesothelioma: Clinicopathologic Correlation of 13 Cases.
    Pavlisko EN; Roggli VL
    Am J Surg Pathol; 2015 Nov; 39(11):1568-75. PubMed ID: 26371785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant solitary fibrous tumour of the prostate: four cases emphasising significant histological and immunophenotypical overlap with sarcomatoid carcinoma.
    Bakhshwin A; Berry RS; Cox RM; Li R; Reynolds JP; Rubin BP; McKenney JK
    Pathology; 2020 Oct; 52(6):643-648. PubMed ID: 32758370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary malignant pericardial sarcomatoid mesothelioma: An autopsy report.
    Muta H; Sugita Y; Ohshima K; Otsubo H
    Pathol Int; 2017 Jun; 67(6):311-315. PubMed ID: 28463437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review.
    Klebe S; Mahar A; Henderson DW; Roggli VL
    Mod Pathol; 2008 Sep; 21(9):1084-94. PubMed ID: 18587319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic usefulness of p16/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.
    Wu D; Hiroshima K; Matsumoto S; Nabeshima K; Yusa T; Ozaki D; Fujino M; Yamakawa H; Nakatani Y; Tada Y; Shimada H; Tagawa M
    Am J Clin Pathol; 2013 Jan; 139(1):39-46. PubMed ID: 23270897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung.
    Berg KB; Churg A
    Am J Surg Pathol; 2017 Sep; 41(9):1221-1225. PubMed ID: 28614203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
    Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F
    Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review.
    Yao DX; Shia J; Erlandson RA; Klimstra DS
    Ultrastruct Pathol; 2004; 28(4):213-28. PubMed ID: 15693633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.
    Terra SB; Aubry MC; Yi ES; Boland JM
    Hum Pathol; 2014 Feb; 45(2):294-302. PubMed ID: 24331839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Programmed Death Ligand-1 (PD-L1) Staining to Separate Sarcomatoid Malignant Mesotheliomas From Benign Mesothelial Reactions.
    Derakhshan F; Ionescu D; Cheung S; Churg A
    Arch Pathol Lab Med; 2020 Feb; 144(2):185-188. PubMed ID: 31484000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.